In 2017, India enacted the Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Act. This landmark law fundamentally shifted the landscape for people living with HIV (PLHIV), establishing a legal framework to protect their rights and end discrimination.

At its core is Section 3, the anti-discrimination clause. This section is broad and powerful. It explicitly prohibits the denial or termination of services to anyone based on their HIV status. This applies to a wide range of sectors, including employment, education, housing, public office, and, crucially, financial services like insurance. The law makes it illegal to treat a person with HIV differently from anyone else in these contexts.

The Act also enshrines two other critical principles: informed consent and confidentiality. No person can be tested for HIV without their explicit, informed consent. This isn't just a signature on a form; it requires pre-test counseling on the implications of the test and post-test counseling to discuss the results. Furthermore, an individual's HIV status is confidential. It cannot be disclosed to anyone, including insurance providers, without the person's written consent. These protections are designed to prevent coercive testing and protect individuals from stigma and prejudice.

For years, acquiring insurance was nearly impossible for PLHIV in India. They were often categorized as 'uninsurable,' leaving them without a financial safety net. Section 22 of the Act directly addresses this injustice.

This section mandates that no insurance provider can discriminate against individuals based on their HIV status. It doesn't mean that policies must be offered without conditions. Instead, it requires that insurance companies treat HIV on par with other chronic or long-term health conditions like diabetes or hypertension. The risk assessment, premium calculation, and policy terms must follow the same principles used for other manageable diseases.

Implementing this mandate falls to the Insurance Regulatory and Development Authority of India (IRDAI). Following the Act, IRDAI has issued specific regulations to guide insurance companies. A significant circular in 2013 first urged insurers to create products for PLHIV, but uptake was slow. It was the legal weight of the 2017 Act that created real momentum. In 2020, IRDAI reinforced its stance, directing all providers to remove discriminatory clauses and ensure their underwriting practices align with the law, treating HIV as another manageable medical condition.

This legal framework ensures that access to financial security through insurance is a right, not a privilege, for people living with HIV in India.

Now, let's check your understanding of these critical regulations.